Dr. Christopher J. Compton, MD

Dr. Compton practices at Baptist Health Louisville in Louisville, Kentucky, part of Baptist Health.

Dr. Compton's NPI, 1033345657, was assigned on June 10, 2009. Dr. Compton graduated from Heersink School of Medicine - Birmingham in 2009. Dr. Compton holds Kentucky license 46039.

Dr. Compton's primary practice is Baptist Health Louisville, at 4000 Kresge Way, Louisville, KY 40207 in Jefferson County. The practice phone is (502) 897-8100.

Dr. Compton's primary practice is Baptist Health Louisville in Louisville, Kentucky, part of Baptist Health. Dr. Compton is also affiliated with Norton Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Compton to 3 more hospitals, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Compton practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Compton's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Compton is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Compton's licenses on file in 3 states: Kentucky, Indiana and Alabama.

Dmand AI lists dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Compton treats.

CMS data shows 5,987 Medicare services from Dr. Compton across 13 procedure codes in 2024, for 252 Medicare patients. Medicare paid $123,530 for them.

CMS counts 252 Medicare patients who saw Dr. Compton in 2026. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Compton's median patient age at 69, with 68% women.

In 2026, Dr. Compton wrote 277 Medicare Part D claims for 140 patients. 94% of them were for generic drugs. CMS names the drug for 227 of them, across 4 drugs with 11 or more claims each, at $1,662 in total drug cost. In 2023, CMS named 261 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Compton for performance year 2026, reported as part of a group. Dr. Compton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Compton, published from 2010 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Magnetic Resonance Imaging, Ophthalmologic Surgical Procedures and Diagnosis, Differential. Dr. Compton has published most often in Ophthalmic Plast Reconstr Surg. Dr. Compton's most frequent co-authors are Jeremy Dustin Clark, MD, William R. Nunery, MD and Taha Z. Shipchandler, MD.

CMS Open Payments shows 154 general payments to Dr. Compton from 29 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 57% of the total. Horizon Pharma plc paid the most, $9,797.

Dr. Compton graduated from Heersink School of Medicine - Birmingham in 2009.

Dr. Compton is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.